MD3987C2 - Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency - Google Patents
Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiencyInfo
- Publication number
- MD3987C2 MD3987C2 MDA20090104A MD20090104A MD3987C2 MD 3987 C2 MD3987 C2 MD 3987C2 MD A20090104 A MDA20090104 A MD A20090104A MD 20090104 A MD20090104 A MD 20090104A MD 3987 C2 MD3987 C2 MD 3987C2
- Authority
- MD
- Moldova
- Prior art keywords
- advancing
- treatment
- diosmine
- cardiac insufficiency
- hepatic cirrhosis
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to medicine, particularly hepatology and can be used for the treatment of patients with advancing hepatic cirrhosis associated with cardiac insufficiency.Summary of the invention consists in the use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency, which is administered per os 600 mg, 1...2 times a day, during 1...3 months.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20090104A MD3987C2 (en) | 2009-09-03 | 2009-09-03 | Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20090104A MD3987C2 (en) | 2009-09-03 | 2009-09-03 | Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency |
Publications (2)
Publication Number | Publication Date |
---|---|
MD3987B1 MD3987B1 (en) | 2009-12-31 |
MD3987C2 true MD3987C2 (en) | 2010-07-31 |
Family
ID=43568856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20090104A MD3987C2 (en) | 2009-09-03 | 2009-09-03 | Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD3987C2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD4232C1 (en) * | 2012-11-08 | 2014-01-31 | Георге АНГЕЛИЧ | Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure |
Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985003864A1 (en) * | 1984-03-01 | 1985-09-12 | Casley Smith John Royle | Treatment of high protein oedemas by direct application of benzo-pyrones |
CH671021A5 (en) * | 1987-05-07 | 1989-07-31 | Espanola Prod Quimicos | Prodn. of hydroxy:ethylated diosmin mixts. - useful for treating intoxication |
FR2661610A1 (en) * | 1990-05-02 | 1991-11-08 | Rhone Poulenc Sante | Novel lyophilised form of diosmin and its preparation |
FR2668705A1 (en) * | 1990-11-06 | 1992-05-07 | Bouchara Sa | Novel skin preparations having a phlebotonic action and process for preparing them |
EP0541874A1 (en) * | 1990-05-11 | 1993-05-19 | Jérôme CORBIERE | Compositions containing diosmin |
FR2692145A1 (en) * | 1992-06-10 | 1993-12-17 | Bellon Labor Sa Roger | Topical compsns. having a vascular protecting and veinotonic action - contain diosmin, fatty acid(s), hydrating agent, neutralising agent, gelling agent and opt. stabilisers, preservatives, colours, perfumes, etc. |
JPH08301757A (en) * | 1995-05-10 | 1996-11-19 | Kureha Chem Ind Co Ltd | Hsp47 synthesis suppressing agent |
NZ280418A (en) * | 1994-11-08 | 1997-03-24 | Adir | Diosmin composition; effervescent granule, in tablet or sachet form containing micronised diosmin |
CA2287363A1 (en) * | 1997-05-13 | 1998-11-19 | Remacle, Jose | Use of a pharmaceutical composition for treating and/or preventing ischemia |
DE19922287A1 (en) * | 1998-05-15 | 1999-11-25 | Coletica Lyon | Cosmetic, dermatological, pharmaceutical, dietetic or food compositions, e.g. for improving skin condition, comprise flavonoid esters |
JP2000023635A (en) * | 1998-07-10 | 2000-01-25 | M P G Kk | Granule nutrient auxiliary food |
WO2000015237A1 (en) * | 1998-09-15 | 2000-03-23 | Korea Research Institute Of Bioscience And Biotechnology | Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases |
KR20000019719A (en) * | 1998-09-15 | 2000-04-15 | 박호군 | Composition comprising diosmin for preventing and treating hyperlipidemia and arteriosclerosis |
KR20010007625A (en) * | 2000-10-06 | 2001-01-26 | 박호군 | Composition for preventing and treating atherosclerosis and hyperlipidemia, comprising diosmin |
KR20010007624A (en) * | 2000-10-06 | 2001-01-26 | 박호군 | Composition for preventing and treating atherosclerosis, hyperlipidemia, hepatic diseases and glycosemia, comprising neohesperidin dihydrochalcone |
WO2002020030A2 (en) * | 2000-09-11 | 2002-03-14 | Michael D Stander | Use of buchu extracts for hypertension |
WO2004032942A1 (en) * | 2002-10-11 | 2004-04-22 | Laboratoires Innothera Sas | Dry oral phlebotonic and vasculoprotective formulation for the treatment of venous insufficiency, capillary fragility and haemorrhoids, in the pharmaceutical form of a chewable tablet containing diosmin |
FR2857665A1 (en) * | 2003-07-16 | 2005-01-21 | Centre Nat Rech Scient | New 3-halo flavone derivatives useful for treating disorders involving an excess of oxidizing species, e.g. cancer, ischemic diseases, dermatosis, neurodegenerative diseases, inflammatory diseases |
US20060040911A1 (en) * | 2003-01-06 | 2006-02-23 | Liao Benedict S | Method for preventing and/or treating the cardiovascular and hepatic diseases induced by hyperlipidemia which comprises administered an effective amount of bioflavonoids extract derived from fructus crataegus (lipid metabolism and fructus crataegus) |
CN1823807A (en) * | 2006-01-11 | 2006-08-30 | 刘展欣 | Micronize diosmin and hesperidine composition suppository |
EP1707192A2 (en) * | 2005-03-30 | 2006-10-04 | Therapicon Srl | Pharmaceutical composition |
MX2007011002A (en) * | 2007-09-07 | 2009-03-09 | World Trade Imp Export Wtie Ag | Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency. |
-
2009
- 2009-09-03 MD MDA20090104A patent/MD3987C2/en not_active IP Right Cessation
Patent Citations (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985003864A1 (en) * | 1984-03-01 | 1985-09-12 | Casley Smith John Royle | Treatment of high protein oedemas by direct application of benzo-pyrones |
CH671021A5 (en) * | 1987-05-07 | 1989-07-31 | Espanola Prod Quimicos | Prodn. of hydroxy:ethylated diosmin mixts. - useful for treating intoxication |
FR2661610A1 (en) * | 1990-05-02 | 1991-11-08 | Rhone Poulenc Sante | Novel lyophilised form of diosmin and its preparation |
EP0541874A1 (en) * | 1990-05-11 | 1993-05-19 | Jérôme CORBIERE | Compositions containing diosmin |
FR2668705A1 (en) * | 1990-11-06 | 1992-05-07 | Bouchara Sa | Novel skin preparations having a phlebotonic action and process for preparing them |
FR2692145A1 (en) * | 1992-06-10 | 1993-12-17 | Bellon Labor Sa Roger | Topical compsns. having a vascular protecting and veinotonic action - contain diosmin, fatty acid(s), hydrating agent, neutralising agent, gelling agent and opt. stabilisers, preservatives, colours, perfumes, etc. |
FR2692145B1 (en) * | 1992-06-10 | 1995-05-05 | Bellon Labor Sa Roger | New composition for topical use containing diosmin. |
NZ280418A (en) * | 1994-11-08 | 1997-03-24 | Adir | Diosmin composition; effervescent granule, in tablet or sachet form containing micronised diosmin |
JPH08301757A (en) * | 1995-05-10 | 1996-11-19 | Kureha Chem Ind Co Ltd | Hsp47 synthesis suppressing agent |
CA2287363A1 (en) * | 1997-05-13 | 1998-11-19 | Remacle, Jose | Use of a pharmaceutical composition for treating and/or preventing ischemia |
DE19922287A1 (en) * | 1998-05-15 | 1999-11-25 | Coletica Lyon | Cosmetic, dermatological, pharmaceutical, dietetic or food compositions, e.g. for improving skin condition, comprise flavonoid esters |
JP2000023635A (en) * | 1998-07-10 | 2000-01-25 | M P G Kk | Granule nutrient auxiliary food |
WO2000015237A1 (en) * | 1998-09-15 | 2000-03-23 | Korea Research Institute Of Bioscience And Biotechnology | Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases |
KR20000019719A (en) * | 1998-09-15 | 2000-04-15 | 박호군 | Composition comprising diosmin for preventing and treating hyperlipidemia and arteriosclerosis |
WO2002020030A2 (en) * | 2000-09-11 | 2002-03-14 | Michael D Stander | Use of buchu extracts for hypertension |
KR20010007625A (en) * | 2000-10-06 | 2001-01-26 | 박호군 | Composition for preventing and treating atherosclerosis and hyperlipidemia, comprising diosmin |
KR20010007624A (en) * | 2000-10-06 | 2001-01-26 | 박호군 | Composition for preventing and treating atherosclerosis, hyperlipidemia, hepatic diseases and glycosemia, comprising neohesperidin dihydrochalcone |
WO2004032942A1 (en) * | 2002-10-11 | 2004-04-22 | Laboratoires Innothera Sas | Dry oral phlebotonic and vasculoprotective formulation for the treatment of venous insufficiency, capillary fragility and haemorrhoids, in the pharmaceutical form of a chewable tablet containing diosmin |
US20060040911A1 (en) * | 2003-01-06 | 2006-02-23 | Liao Benedict S | Method for preventing and/or treating the cardiovascular and hepatic diseases induced by hyperlipidemia which comprises administered an effective amount of bioflavonoids extract derived from fructus crataegus (lipid metabolism and fructus crataegus) |
FR2857665A1 (en) * | 2003-07-16 | 2005-01-21 | Centre Nat Rech Scient | New 3-halo flavone derivatives useful for treating disorders involving an excess of oxidizing species, e.g. cancer, ischemic diseases, dermatosis, neurodegenerative diseases, inflammatory diseases |
EP1707192A2 (en) * | 2005-03-30 | 2006-10-04 | Therapicon Srl | Pharmaceutical composition |
CN1823807A (en) * | 2006-01-11 | 2006-08-30 | 刘展欣 | Micronize diosmin and hesperidine composition suppository |
MX2007011002A (en) * | 2007-09-07 | 2009-03-09 | World Trade Imp Export Wtie Ag | Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency. |
Non-Patent Citations (1)
Title |
---|
Matcovschi C., Procopişin V., Parii B. Compendium medicamentorum. Tipografia Centrală, Chişinău, 2001, p. 759 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD4232C1 (en) * | 2012-11-08 | 2014-01-31 | Георге АНГЕЛИЧ | Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure |
Also Published As
Publication number | Publication date |
---|---|
MD3987B1 (en) | 2009-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011007589A (en) | Treatment of a cancer using a combination of bendamustine and an anti-cd20 antibody. | |
PE20142319A1 (en) | MULTIPLE SCLEROSIS TREATMENT WITH A COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE | |
NZ597378A (en) | Treatment of multiple sclerosis with laquinimod | |
EA201500552A1 (en) | RELAXIN TREATMENT TREATMENT ASSOCIATED WITH ACUTE HEALTH INSUFFICIENCY | |
NZ714963A (en) | Compositions and methods for treating anemia | |
MY173215A (en) | Acetylcysteine compositions and methods of use thereof | |
AR086356A1 (en) | PHARMACEUTICAL COMBINATION FOR USE IN THE TREATMENT OF PATIENTS WHO HAVE TYPE 2 DIABETES | |
UA105191C2 (en) | Treatment with pirfenidone of patients with abnormal liver function | |
MX2016011333A (en) | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine. | |
MX2010008433A (en) | Use of ranolazine for the treatment of cardiovascular diseases. | |
NZ588886A (en) | Use of dronedarone alone or in combination for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level | |
MD3987C2 (en) | Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency | |
NZ604009A (en) | A combination composition comprising ibuprofen and paracetamol | |
MX2018011293A (en) | Prolonged release pharmaceutical composition comprising cysteamine or salt thereof. | |
MD3986C2 (en) | Use of Diosmine for the treatment of portal gastropathies in the hepatic cirrhosis | |
MD4232B1 (en) | Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure | |
MD596Y (en) | Method for treating the chronic viral hepatitis C | |
MD4231C1 (en) | Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis | |
UA101141U (en) | The method of correction of the dyslipidemia in patients with myocardial infarction in combination with nonalcoholic steatohepatitis | |
GB2474209A (en) | Sertraline composition | |
UA33149U (en) | Method for treating arrhythmia in patients with minor structural abnormalities of heart | |
UA37658U (en) | Device for thoracocentesis | |
UA75872U (en) | Method for rehabilitation of patients with ischemic heart disease in combination with diabetes mellitus type 2 | |
MD3476F1 (en) | Method of treating the essential hypertension associated with pronounced depressions | |
UA92865C2 (en) | Method for treatment of non-hospital pneumony in patients infected with Chlamydophila pneumoniae, at risk of destabilization of ACCOMPANYING ischemic heart desease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |